Literature DB >> 26523346

Epidemiological factors associated with ESBL- and non ESBL-producing E. coli causing urinary tract infection in general practice.

Frederik Boëtius Hertz1,2, Kristian Schønning1, Steen Christian Rasmussen1, Pia Littauer1, Jenny Dahl Knudsen1, Anders Løbner-Olesen2, Niels Frimodt-Møller1.   

Abstract

The purpose of the study was to evaluate how use of antibiotics precedes the presence of ESBL-producing E.coli in general practice. The authors performed a triple-case-control study where three case groups were individually compared to a single control group of uninfected individuals. Urine samples were prospectively collected and retrospective statistical analyses were done. This study included 98 cases with urinary tract infection (UTI) caused by ESBL-producing E. coli, 174 with antibiotic-resistant (non-ESBL) E. coli, 177 with susceptible E. coli and 200 with culture negative urine samples. Case groups had significantly higher use of antibiotics than the control group within 30 days before infection (p < 0.0001). The ESBL group had significantly more hospital admissions than the other case groups (p < 0.05). Hospital admission was an independent risk factor for community onset UTI by ESBL-producing E. coli. Exposure to antibiotics was a risk factor for UTI with E. coli, while prior antibiotic usage was not an indisputable predictor for infection with ESBL-producing E.coli in general practice.

Entities:  

Keywords:  ESBL; Escherichia coli; UTI; community-acquired; risk factors

Mesh:

Substances:

Year:  2015        PMID: 26523346     DOI: 10.3109/23744235.2015.1103895

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  13 in total

1.  The authors respond to "Underlying maternal infection likely cause of study findings".

Authors:  Anick Bérard; Flory T Muanda; Odile Sheehy
Journal:  CMAJ       Date:  2017-07-10       Impact factor: 8.262

2.  Use of antibiotics during pregnancy and risk of spontaneous abortion.

Authors:  Flory T Muanda; Odile Sheehy; Anick Bérard
Journal:  CMAJ       Date:  2017-05-01       Impact factor: 8.262

3.  Association of systemic antimicrobials with the expression of beta-lactamases in bacteria cultured from urological patients.

Authors:  Catherine S Forster; Eleanor A Powell; Barbara DeBurger; Joshua Courter; David B Haslam; Joel E Mortensen
Journal:  Diagn Microbiol Infect Dis       Date:  2019-02-10       Impact factor: 2.803

4.  Use of trimethoprim-sulfamethoxazole during pregnancy and risk of spontaneous abortion: a nested case control study.

Authors:  Flory T Muanda; Odile Sheehy; Anick Bérard
Journal:  Br J Clin Pharmacol       Date:  2018-03-25       Impact factor: 4.335

5.  Antimicrobial susceptibilities of aerobic and facultative gram-negative bacilli isolated from Chinese patients with urinary tract infections between 2010 and 2014.

Authors:  Qiwen Yang; Hui Zhang; Yao Wang; Zhipeng Xu; Ge Zhang; Xinxin Chen; Yingchun Xu; Bin Cao; Haishen Kong; Yuxing Ni; Yunsong Yu; Ziyong Sun; Bijie Hu; Wenxiang Huang; Yong Wang; Anhua Wu; Xianju Feng; Kang Liao; Yanping Luo; Zhidong Hu; Yunzhuo Chu; Juan Lu; Jianrong Su; Bingdong Gui; Qiong Duan; Shufang Zhang; Haifeng Shao; Robert E Badal
Journal:  BMC Infect Dis       Date:  2017-03-06       Impact factor: 3.090

6.  Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing Escherichia coli bacteremia: a retrospective study from 2013 to 2016.

Authors:  Tingting Xiao; Kai Yang; Yanzi Zhou; Shuntian Zhang; Jinru Ji; Chaoqun Ying; Ping Shen; Yonghong Xiao
Journal:  Antimicrob Resist Infect Control       Date:  2019-08-27       Impact factor: 4.887

7.  ESBL-production in Escherichia coli and Klebsiella pneumoniae isolates from Nigeria.

Authors:  Frederik B Hertz; Fillip Jansåker; Kenneth O Okon; Ibrahim S Abdulmumin; Joseph O Onah; Joshua Ladan; Jenny D Knudsen
Journal:  Microbiologyopen       Date:  2019-02-22       Impact factor: 3.139

8.  Community-Acquired, Extended-Spectrum β-Lactamase-Producing and Extensively Drug-Resistant Escherichia coli in a 28-Year-Old Pyelonephritis Patient Lacking Risk Factors.

Authors:  Connor W Evins; Caroline M Sutton; Sarah T Withers; Jennifer T Grier; Christine M G Schammel; Steven E Fiester
Journal:  Antibiotics (Basel)       Date:  2021-05-05

9.  Antibiotic prescriptions and risk factors for antimicrobial resistance in patients hospitalized with urinary tract infection: a matched case-control study using the French health insurance database (SNDS).

Authors:  Marion Opatowski; Christian Brun-Buisson; Mehdi Touat; Jérôme Salomon; Didier Guillemot; Philippe Tuppin; Laurence Watier
Journal:  BMC Infect Dis       Date:  2021-06-14       Impact factor: 3.090

Review 10.  Risk factors for aquiring multidrug-resistant organisms in urinary tract infections: A systematic literature review.

Authors:  Justin Tenney; Nicholas Hudson; Hazar Alnifaidy; Justin Ting Cheung Li; Kathy Harriet Fung
Journal:  Saudi Pharm J       Date:  2018-02-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.